Early blockade of type-I IFNs by type-I IFN receptor blocking antibodies following infection with live attenuated viral vaccine YFV-17D and Zika virus enhanced the antigen presentation by DCs, expanded the antigen-specific CD8+ T cell populations and produced long-lasting immunological memory that conferred improved protection upon reinfection58. The gene discussed is CD8A; the disease is infection.